Logo image of AMRC

AMERESCO INC-CL A (AMRC) Stock Fundamental Analysis

NYSE:AMRC - New York Stock Exchange, Inc. - US02361E1082 - Common Stock - Currency: USD

18.69  +0.73 (+4.06%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AMRC. AMRC was compared to 49 industry peers in the Construction & Engineering industry. AMRC has a bad profitability rating. Also its financial health evaluation is rather negative. AMRC is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year AMRC was profitable.
In the past year AMRC had a positive cash flow from operations.
In the past 5 years AMRC has always been profitable.
In the past 5 years AMRC reported 4 times negative operating cash flow.
AMRC Yearly Net Income VS EBIT VS OCF VS FCFAMRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

AMRC has a Return On Assets (1.30%) which is comparable to the rest of the industry.
With a Return On Equity value of 5.35%, AMRC perfoms like the industry average, outperforming 48.98% of the companies in the same industry.
AMRC has a Return On Invested Capital of 2.07%. This is in the lower half of the industry: AMRC underperforms 65.31% of its industry peers.
AMRC had an Average Return On Invested Capital over the past 3 years of 3.15%. This is significantly below the industry average of 16.67%.
Industry RankSector Rank
ROA 1.3%
ROE 5.35%
ROIC 2.07%
ROA(3y)2.11%
ROA(5y)2.51%
ROE(3y)8%
ROE(5y)8.99%
ROIC(3y)3.15%
ROIC(5y)3.6%
AMRC Yearly ROA, ROE, ROICAMRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

AMRC has a Profit Margin (2.97%) which is in line with its industry peers.
In the last couple of years the Profit Margin of AMRC has declined.
AMRC's Operating Margin of 4.84% is in line compared to the rest of the industry. AMRC outperforms 48.98% of its industry peers.
In the last couple of years the Operating Margin of AMRC has declined.
AMRC's Gross Margin of 14.31% is in line compared to the rest of the industry. AMRC outperforms 40.82% of its industry peers.
In the last couple of years the Gross Margin of AMRC has declined.
Industry RankSector Rank
OM 4.84%
PM (TTM) 2.97%
GM 14.31%
OM growth 3Y-16.55%
OM growth 5Y-4.81%
PM growth 3Y-17.89%
PM growth 5Y-8.97%
GM growth 3Y-8.6%
GM growth 5Y-5.69%
AMRC Yearly Profit, Operating, Gross MarginsAMRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AMRC is destroying value.
AMRC has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AMRC has more shares outstanding
AMRC has a better debt/assets ratio than last year.
AMRC Yearly Shares OutstandingAMRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AMRC Yearly Total Debt VS Total AssetsAMRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

AMRC has an Altman-Z score of 1.04. This is a bad value and indicates that AMRC is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.04, AMRC is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.55 is on the high side and indicates that AMRC has dependencies on debt financing.
AMRC has a worse Debt to Equity ratio (1.55) than 67.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF N/A
Altman-Z 1.04
ROIC/WACC0.22
WACC9.52%
AMRC Yearly LT Debt VS Equity VS FCFAMRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

AMRC has a Current Ratio of 1.57. This is a normal value and indicates that AMRC is financially healthy and should not expect problems in meeting its short term obligations.
AMRC has a better Current ratio (1.57) than 77.55% of its industry peers.
AMRC has a Quick Ratio of 1.56. This is a normal value and indicates that AMRC is financially healthy and should not expect problems in meeting its short term obligations.
AMRC has a Quick ratio of 1.56. This is amongst the best in the industry. AMRC outperforms 81.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.56
AMRC Yearly Current Assets VS Current LiabilitesAMRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

The earnings per share for AMRC have decreased strongly by -10.53% in the last year.
The Earnings Per Share has been growing slightly by 3.47% on average over the past years.
AMRC shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.13%.
Measured over the past years, AMRC shows a quite strong growth in Revenue. The Revenue has been growing by 15.34% on average per year.
EPS 1Y (TTM)-10.53%
EPS 3Y-12.06%
EPS 5Y3.47%
EPS Q2Q%0%
Revenue 1Y (TTM)30.13%
Revenue growth 3Y13.34%
Revenue growth 5Y15.34%
Sales Q2Q%18.24%

3.2 Future

AMRC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.33% yearly.
The Revenue is expected to grow by 8.47% on average over the next years. This is quite good.
EPS Next Y-23.2%
EPS Next 2Y4.72%
EPS Next 3Y17.49%
EPS Next 5Y16.33%
Revenue Next Year7.13%
Revenue Next 2Y8.45%
Revenue Next 3Y9.51%
Revenue Next 5Y8.47%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AMRC Yearly Revenue VS EstimatesAMRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
AMRC Yearly EPS VS EstimatesAMRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.32, the valuation of AMRC can be described as rather expensive.
AMRC's Price/Earnings ratio is rather cheap when compared to the industry. AMRC is cheaper than 91.84% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.41. AMRC is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 16.71, AMRC is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AMRC indicates a rather cheap valuation: AMRC is cheaper than 83.67% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.19. AMRC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 18.32
Fwd PE 16.71
AMRC Price Earnings VS Forward Price EarningsAMRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AMRC is valued a bit cheaper than the industry average as 73.47% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.18
AMRC Per share dataAMRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

AMRC's earnings are expected to grow with 17.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)5.28
EPS Next 2Y4.72%
EPS Next 3Y17.49%

0

5. Dividend

5.1 Amount

No dividends for AMRC!.
Industry RankSector Rank
Dividend Yield N/A

AMERESCO INC-CL A

NYSE:AMRC (7/14/2025, 3:41:47 PM)

18.69

+0.73 (+4.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners93.66%
Inst Owner Change-1.63%
Ins Owners7.71%
Ins Owner Change10.4%
Market Cap983.09M
Analysts75.29
Price Target21.08 (12.79%)
Short Float %10.22%
Short Ratio5.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)28.04%
Min EPS beat(2)-8.27%
Max EPS beat(2)64.35%
EPS beat(4)1
Avg EPS beat(4)-10.47%
Min EPS beat(4)-66.19%
Max EPS beat(4)64.35%
EPS beat(8)3
Avg EPS beat(8)-4.78%
EPS beat(12)5
Avg EPS beat(12)-1.18%
EPS beat(16)9
Avg EPS beat(16)4.47%
Revenue beat(2)1
Avg Revenue beat(2)6.22%
Min Revenue beat(2)-0.4%
Max Revenue beat(2)12.84%
Revenue beat(4)3
Avg Revenue beat(4)6.79%
Min Revenue beat(4)-0.4%
Max Revenue beat(4)13.75%
Revenue beat(8)6
Avg Revenue beat(8)5.69%
Revenue beat(12)9
Avg Revenue beat(12)4.87%
Revenue beat(16)11
Avg Revenue beat(16)3.9%
PT rev (1m)1.31%
PT rev (3m)-12.06%
EPS NQ rev (1m)-21.05%
EPS NQ rev (3m)-75%
EPS NY rev (1m)0.61%
EPS NY rev (3m)0.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.65%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.42%
Valuation
Industry RankSector Rank
PE 18.32
Fwd PE 16.71
P/S 0.54
P/FCF N/A
P/OCF 14.36
P/B 0.97
P/tB 1.05
EV/EBITDA 14.18
EPS(TTM)1.02
EY5.46%
EPS(NY)1.12
Fwd EY5.99%
FCF(TTM)-7.16
FCFYN/A
OCF(TTM)1.3
OCFY6.97%
SpS34.68
BVpS19.24
TBVpS17.76
PEG (NY)N/A
PEG (5Y)5.28
Profitability
Industry RankSector Rank
ROA 1.3%
ROE 5.35%
ROCE 2.62%
ROIC 2.07%
ROICexc 2.11%
ROICexgc 2.17%
OM 4.84%
PM (TTM) 2.97%
GM 14.31%
FCFM N/A
ROA(3y)2.11%
ROA(5y)2.51%
ROE(3y)8%
ROE(5y)8.99%
ROIC(3y)3.15%
ROIC(5y)3.6%
ROICexc(3y)3.29%
ROICexc(5y)3.76%
ROICexgc(3y)3.41%
ROICexgc(5y)3.91%
ROCE(3y)3.99%
ROCE(5y)4.56%
ROICexcg growth 3Y-23.67%
ROICexcg growth 5Y-13.36%
ROICexc growth 3Y-23.08%
ROICexc growth 5Y-12.71%
OM growth 3Y-16.55%
OM growth 5Y-4.81%
PM growth 3Y-17.89%
PM growth 5Y-8.97%
GM growth 3Y-8.6%
GM growth 5Y-5.69%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF N/A
Debt/EBITDA 8.58
Cap/Depr 471.74%
Cap/Sales 24.39%
Interest Coverage 0.84
Cash Conversion 37.49%
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 1.56
Altman-Z 1.04
F-Score6
WACC9.52%
ROIC/WACC0.22
Cap/Depr(3y)645.79%
Cap/Depr(5y)553.31%
Cap/Sales(3y)27.71%
Cap/Sales(5y)23.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.53%
EPS 3Y-12.06%
EPS 5Y3.47%
EPS Q2Q%0%
EPS Next Y-23.2%
EPS Next 2Y4.72%
EPS Next 3Y17.49%
EPS Next 5Y16.33%
Revenue 1Y (TTM)30.13%
Revenue growth 3Y13.34%
Revenue growth 5Y15.34%
Sales Q2Q%18.24%
Revenue Next Year7.13%
Revenue Next 2Y8.45%
Revenue Next 3Y9.51%
Revenue Next 5Y8.47%
EBIT growth 1Y6.36%
EBIT growth 3Y-5.42%
EBIT growth 5Y9.79%
EBIT Next Year90.63%
EBIT Next 3Y37.6%
EBIT Next 5Y27.24%
FCF growth 1Y-2.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2114.03%
OCF growth 3YN/A
OCF growth 5YN/A